Independent pricing research. We may earn a commission from provider links — how we make money.

Foundayo™ (orforglipron): what the first GLP-1 pill-without-restrictions actually costs

Foundayo (orforglipron) is Eli Lilly's once-daily oral GLP-1, FDA-approved on April 1, 2026 — a small-molecule pill with no injections, and unlike oral semaglutide, no complicated fasting-window dosing rules. It promptly reset the bottom of the GLP-1 price market. Here's every way to pay for it, cheapest first.

PathMonthly costWho qualifies
Commercial insurance + Lilly savings cardas low as $25/moCommercially insured patients whose plan covers it
Medicare Part D manufacturer program$50/moEligible Part D members, since July 1, 2026 — ask your prescriber
Self-pay via LillyDirectfrom $149/moAnyone with a prescription; no insurance involved
Via telehealth platform (e.g., Ro)med cost + $74–149/mo membershipIf you want a platform managing prescribing and refills

How to get it for $149

The self-pay route needs exactly two things: a prescription from any licensed clinician (your own doctor works fine), and a LillyDirect Self Pay Journey order. No membership, no subscription to a platform. If you don't have a prescriber, any telehealth provider can evaluate you — just know that an ongoing platform membership is a convenience purchase on top of the $149, not a requirement.

How it compares

The one-sentence takeaway

If you're paying cash for a first GLP-1 in late 2026, the question your clinician should help you answer is "Foundayo or Wegovy pill at ~$149–199" — not "which $300 program" — unless there's a clinical reason for an injectable.

See every GLP-1 cash price Compare telehealth providers

Sources (verified Aug 25, 2026): Eli Lilly investor press release, Foundayo FDA approval (Apr 1, 2026) and pricing/program details incl. Medicare Part D program effective Jul 1, 2026; LillyDirect Self Pay Journey; AJMC approval coverage. Whether any medication is appropriate for you is a decision for a licensed clinician — see our medical disclaimer.